Flerie AB (publ) (STO: FLERIE)

Sweden flag Sweden · Delayed Price · Currency is SEK
48.23
-0.46 (-0.94%)
Jan 31, 2025, 5:29 PM CET
-11.99%
Market Cap 3.77B
Revenue (ttm) 2.70M
Net Income (ttm) -228.00M
Shares Out 78.07M
EPS (ttm) -3.24
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 18,070
Average Volume 25,128
Open 49.00
Previous Close 48.69
Day's Range 47.09 - 49.00
52-Week Range 41.03 - 57.00
Beta n/a
RSI 50.66
Earnings Date Jan 22, 2025

About Flerie AB

Flerie AB (publ) is a venture capital firm specializing in early-stage investments. It seeks to invest in biotech and pharma companies engaged in drug development and associated tools or applications tackling major medical challenges of our time. The firm seeks to invest in Europe, United States and Israel. Flerie AB (publ) was founded in 2011 and is based in Stockholm, Sweden with additional office in London, United Kingdom. [Read more]

Industry Pharmaceutical Preparations
Founded 2011
Employees 7
Stock Exchange Nasdaq Stockholm
Ticker Symbol FLERIE
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.